tiprankstipranks
Salesforce (CRM)
NYSE:CRM

Salesforce (CRM) Technical Analysis

21,003 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Salesforce’s (CRM) Moving Averages Convergence Divergence (MACD) indicator is 6.11, suggesting Salesforce is a Sell.
Salesforce’s (CRM) 20-Day exponential moving average is 289.45, while Salesforce’s (CRM) share price is $303, making it a Buy.
Salesforce’s (CRM) 50-Day exponential moving average is 275.91, while Salesforce’s (CRM) share price is $303, making it a Buy.

Salesforce (CRM) Pivot Points

Feb 29, 2024, 01:55 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
291.67
294.13
296.82
299.28
301.97
304.43
307.12
Fibonacci
294.13
296.10
297.32
299.28
301.25
302.47
304.43
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Salesforce (CRM) Moving Averages

Feb 29, 2024, 01:55 PM
Period
Simple
Exponential
MA5
297.22Buy
296.98Buy
MA10
292.69Buy
293.87Buy
MA20
289.60Buy
289.45Buy
MA50
276.83Buy
275.91Buy
MA100
248.49Buy
257.81Buy
MA200
231.19Buy
236.93Buy
Salesforce’s (CRM) 10-Day exponential moving average is 293.87, while Salesforce’s (CRM) share price is $303, making it a Buy.
Salesforce’s (CRM) 100-Day exponential moving average is 257.81, while Salesforce’s (CRM) share price is $303, making it a Buy.
Salesforce’s (CRM) stock price is $303 and Salesforce’s (CRM) 50-day simple moving average is 276.83, creating a Buy signal.
Salesforce’s (CRM) stock price is $303 and Salesforce’s (CRM) 100-day simple moving average is 248.49, creating a Buy signal.
Salesforce’s (CRM) stock price is $303 and Salesforce’s (CRM) 200-day simple moving average is 231.19, creating a Buy signal.

Salesforce (CRM) Technical Indicators

Feb 29, 2024, 01:55 PM
Name
Value
Implied Action
RSI (14)
65.21
Neutral
STOCH (9,6)
84.84
Sell
STOCHRSI (14)
85.62
Sell
MACD (12,26)
6.11
Sell
ADX (14)
23.62
Neutral
Williams %R
-14.81
Sell
CCI (14)
142.01
Sell
ATR (14)
6.32
-
Ultimate Oscillator
60.21
Neutral
ROC
3.78
Buy
Salesforce’s (CRM) Relative Strength Index (RSI) is 65.21, creating a Neutral signal.
Salesforce’s (CRM) Trend Strength Indicator (ADX) is 23.62, creating a Neutral signal.
Salesforce’s (CRM) Commodity Channel Index (CCI) is 142.01, creating a Sell signal.
Salesforce’s (CRM) Price Rate of Change (ROC) is 3.78, creating a Buy signal.

FAQ

Is CRM a Buy, Hold, or Sell?
Based on CRM’s technical indicators, CRM is a Buy.
    What is CRM’s RSI (14)?
    CRM’s RSI (14) is 65.21, which suggests CRM is a Neutral.
      What is CRM’s MACD?
      CRM’s MACD is 6.11, which suggests CRM is a Sell.
        What is CRM’s 5-day moving average?
        CRM’s 5-day moving average is 297.22, which suggests CRM is a Buy.
          What is CRM’s 20-day moving average?
          CRM 20-day moving average is 289.60, which suggests CRM is a Buy.
            What is CRM’s 50-day moving average?
            CRM’s 50-day moving average is 276.83, which suggests CRM is a Buy.
              What is CRM’s 200-day moving average?
              CRM’s 200-day moving average is 231.19, which suggests CRM is a Buy.
                What is CRM’s Williams % R (14)?
                CRM’s Williams % R (14) is -14.81, which suggests CRM is a Sell.
                  What is CRM’s CCI (14)?
                  CRM’s CCI (14) is 142.01, which suggests CRM is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis